The Murdoch Children's Research Institute and The Royal Children's Hospital Melbourne are trialling a new device — Rhinomed Junior — to test children for COVID-19.
As we live through the lengthening tail of a persistent pandemic, it is challenging to consider the simpler medicines landscape of 20 years ago.
Advancements in laboratory techniques and improvements in the overall management of couples experiencing infertility amongst other factors have led to significant improvements in IVF success rates.
A parent-led therapy that supports social development can reduce likelihood of an autism diagnosis in children showing early behavioural signs of the condition.
Artrya's non-invasive diagnostic support solution to detect coronary artery disease has commenced its first market pilot with Perth-based radiology practice Envision Medical Imaging.
An antiviral surface coating technology developed at The University of Queensland could provide an extra layer of protection against COVID-19 and the flu.
PanKind and QIMR Berghofer Medical Research Institute have teamed up to trial a new service to support carers through the devastating impact of pancreatic cancer.
The SHPA has welcomed the medicines agreements as vital to protecting patients against shortages and ensuring medicines are accessible, available and cost-efficient.
The first large-scale, long-term trial of a new strategy using combinations of very low doses in one capsule has demonstrated significantly improved control of high blood pressure.
The Australian Commission on Safety and Quality in Health Care is seeking comments on the draft clinical care standard for opioid analgesics.
While antimicrobial use in the community is decreasing, overprescribing and inappropriate prescribing continue to be problematic.
RMIT researchers have found a way to better pinpoint the 'golden window' when a womb is ready for pregnancy.
Clearly, we cannot rebuild all our hospital ventilation systems to cope with the current outbreak. However, there are tangible things that can be done now and in future.
The O2matic PRO from BOC is designed to quickly stabilise arterial oxygen saturation in patients suffering from conditions that can lead to respiratory distress.
The Australian Government is working with the states and territories to purpose build quarantine accommodation hubs outside of major cities.